Almost a year after buying Kate Therapeutics, Novartis has scooped up another San Diego-based muscle dystrophy biotech in one of the biggest acquisitions of 2025 so far.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
